Literature DB >> 21868751

The impact of transurethral procedures for benign prostate hyperplasia on male sexual function: a meta-analysis.

Huan-Tao Zong1, Xiao-Xia Peng, Chen-Chen Yang, Yong Zhang.   

Abstract

The effect of transurethral procedures for benign prostate hyperplasia (BPH) on male sexual function is still controversial, and we conducted this meta-analysis to compare the effects of different transurethral surgical procedures for the treatment of symptomatic BPH on male erectile function (EF) and ejaculatory function (EJF). Databases, including MEDLINE, EMBASE, and the Cochrane Controlled Trial Register, were searched to identify randomized controlled trials (RCT) that compared watchful waiting, transurethral electrovaporization (TUEVP) or holmium laser treatment (HLT) with transurethral resection of the prostate (TURP). Trials were included if they were RCTs, contained fully available data, compared with conventional TURP for BPH, and referred to male EF and EJF. A total of 12 RCTs involving a total of 1889 subjects were selected for analysis, including 2 trials comparing TURP and watchful waiting, 6 comparing TURP with TUEVP, and 4 comparing TURP with HLT. TURP was associated with a higher occurrence of retrograde ejaculation compared with watchful waiting but not to TUEVP (P = .95) or HLT (P = .37) and associated with a lower incidence of male erectile dysfunction compared with TUEVP (P = .04) but not HLT. According to the analysis, TURP lead to a higher prevalence of retrograde ejaculation compared with watchful waiting but had less of an effect on EF than TUEVP. TURP did not have a significantly different effect on EF or EJF compared with HLT.

Entities:  

Mesh:

Year:  2011        PMID: 21868751     DOI: 10.2164/jandrol.111.013490

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  13 in total

Review 1.  The Effect of LUTS/BPH and Treatments on Ejaculatory Function.

Authors:  Michelle Herberts; Michael Butcher; Tobias Köhler
Journal:  Curr Urol Rep       Date:  2016-07       Impact factor: 3.092

2.  Longitudinal changes in erectile function after thulium:YAG prostatectomy for the treatment of benign prostatic obstruction: a 1-year follow-up study.

Authors:  Jae Seung Chung; Sang Hyun Park; Cheol Kyu Oh; Seong Cheol Kim; Taek Sang Kim; Pil Moon Kang; Won Ik Seo; Wan Seok Kim; Jang Ho Yoon; Dong Ii Kang; Kweon Sik Min; Jae Ii Chung
Journal:  Lasers Med Sci       Date:  2017-07-06       Impact factor: 3.161

3.  Long-term sexual outcomes after holmium laser enucleation of the prostate: which patients could benefit the most?

Authors:  P Capogrosso; E Ventimiglia; M Ferrari; A Serino; L Boeri; U Capitanio; A Briganti; R Damiano; F Montorsi; A Salonia
Journal:  Int J Impot Res       Date:  2016-07-28       Impact factor: 2.896

4.  Minimizing Sexual Dysfunction in BPH Surgery.

Authors:  Joon Yau Leong; Amir S Patel; Ranjith Ramasamy
Journal:  Curr Sex Health Rep       Date:  2019-07-20

Review 5.  Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia.

Authors:  Neal Shore; Ronald Tutrone; Claus G Roehrborn
Journal:  Ther Adv Urol       Date:  2019-01-14

Review 6.  The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis.

Authors:  Zhuo Li; Ping Chen; Jun Wang; Qi Mao; Han Xiang; Xiao Wang; Xinghuan Wang; Xinhua Zhang
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

7.  Bipolar transurethral enucleation and resection of the prostate: Whether it is ready to supersede TURP?

Authors:  Peng Xu; Abai Xu; Binshen Chen; Shaobo Zheng; Yawen Xu; Hulin Li; Haiyan Shen; Chunxiao Liu
Journal:  Asian J Urol       Date:  2017-12-08

8.  Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement.

Authors:  Neal Shore; Ronald Tutrone; Mitchell Efros; Mohamed Bidair; Barton Wachs; Susan Kalota; Sheldon Freedman; James Bailen; Richard Levin; Stephen Richardson; Jed Kaminetsky; Jeffrey Snyder; Barry Shepard; Kenneth Goldberg; Alan Hay; Steven Gange; Ivan Grunberger
Journal:  World J Urol       Date:  2018-01-29       Impact factor: 4.226

9.  Investigation of prostate resected weight on postoperative sexual dysfunction following transurethral resection of prostate surgery: a population-based study.

Authors:  Fu-Chao Liu; Shih-Jyun Shen; Jr-Rung Lin; Huang-Ping Yu
Journal:  Ther Clin Risk Manag       Date:  2019-01-10       Impact factor: 2.423

10.  Fexapotide Triflutate Induces Selective Prostate Glandular Pharmaco-Ablation in the Rat.

Authors:  Paul Averback; Rajna Gohal; Marta Fuska; Kathleen Prins; Ping Wang
Journal:  Res Rep Urol       Date:  2019-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.